Golimumab for the Treatment of Hidradenitis Suppurativa in Patients with Previous TNF-α Treatment Failure

North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: Diagnosis, Evaluation, and the use of Complementary and Procedural Management

(2019) A. Alikhan et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part II: Topical, Intralesional, and Systemic medical Management

(2019) A. Alikhan et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Determining the Optimal Dose of Infliximab for Treatment of Hidradenitis Suppurativa

(2019) Ashley N. Oskardmay et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Golimumab for the treatment of ulcerative colitis

(2017) Mathurin Flamant et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Concomitant hidradenitis suppurativa and pyostomatitis vegetans in silent ulcerative colitis successfully treated with golimumab

(2016) Antonio Tursi   DIGESTIVE AND LIVER DISEASE

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

(2016) Alexa B. Kimball et al.   NEW ENGLAND JOURNAL OF MEDICINE

Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment

(2014) A.B. Kimball et al.   BRITISH JOURNAL OF DERMATOLOGY

Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α

(2014) David J. Shealy et al.   mAbs

Failure of Anti-Interleukin-1 Therapy in Severe Hidradenitis Suppurativa: A Case Report

(2013) H.H. van der Zee et al.   DERMATOLOGY